CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Carbamazepine does not prevent Oxaliplatin-Related Neurotoxicity in Patients with Advanced Colorectal Cancer: Final Results of a Randomised, Controlled, Multicenter Phase II Study
DOI 10.1055/s-2006-955491
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS von Delius, F Eckel, S Wagenpfeil, M Mayr, K Stock, F Kullmann, F Obermeier, J Erdmann, R Schmelz, S Quasthoff, H Adelsberger, RM Schmid, C Lersch
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe10/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Oxaliplatin-induced neurotoxicity is a growing, relevant clinical problem. In this study we evaluated the efficacy and safety of carbamazepine for prevention of oxaliplatin-associated neuropathy in patients with advanced colorectal cancer. Methods: Chemotherapeutic treatment consisted of oxaliplatin 85mg/m2 given biweekly and weekly folinic acid 500mg/m2 followed by a 24-hour infusion of 5-FU 2000mg/m2 (…
Zitieren
Zitierempfehlung
S von Delius, F Eckel, S Wagenpfeil, M Mayr, K Stock, F Kullmann, F Obermeier, J Erdmann, R Schmelz, S Quasthoff, H Adelsberger, RM Schmid, C Lersch (2006) Carbamazepine does not prevent Oxaliplatin-Related Neurotoxicity in Patients with Advanced Colorectal Cancer: Final Results of a Randomised, Controlled, Multicenter Phase II Study. Zeitschrift für Gastroenterologie (10). https://doi.org/10.1055/s-2006-955491
Mit CareLit weiterarbeiten